FM
FMR LLC disclosed a 9.8% stake in AVTX
FMR LLC reported owning 9.8% of Avalo Therapeutics, Inc. (AVTX) (5,250,181 shares) in a Schedule 13G filed Nov 5, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 5, 2026
- Source
- Schedule 13G